Collins stressed that the final product will be safe despite the speed at which it's being produced
To make that goal feasible, the NIH convened an unprecedented alliance called, or ACTIV, which brings together seven governmental agencies, 20 pharmaceutical and biotechnology companies, and four major non-profits—far more collective brainpower than has ever come together under one umbrella under similar circumstances.
This included 50 candidate vaccines that had to be pared down to the most promising efforts that posed the least risk to patients. For example, ACTIV is not considering what are known as One looming question, from a high altitude, is how the U.S. government could have been better prepared to rapidly respond to the pandemic, and, on the flip side, whether the lessons learned from COVID-19 can be consecrated for future health crises.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 vaccine: Early Oxford trial data to be published next weekThe World Health Organization's chief scientist said in June that the vaccine was probably the most advanced in terms of development.
Read more »
Potential COVID-19 vaccine shows promise in early trial'It is good news that it's not bad news,' infectious disease expert Dr. Michael Osterholm says about promising results from Moderna's first COVID-19 vaccine trial. 'But remember, we're in the first 100 yards of a marathon.'
Read more »
Early-stage trial data on AstraZeneca COVID-19 vaccine due July 20 - LancetThe Lancet medical journal said on Wednesday it will publish keenly-awaited phase 1 clinical trial data on a potential COVID-19 vaccine being developed by Astrazeneca and Oxford University on Monday.
Read more »
Early-stage trial data on AstraZeneca COVID-19 vaccine due Monday - LancetEarly-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20, The Lancet medical journal said on Wednesday.
Read more »
COVID Vaccine Tested in People Shows Early PromisePROMISING VACCINE NEWS: The first COVID-19 vaccine tested in humans brought about an immune response in every person in the test and did not have significant side effects, researchers report.
Read more »
Moderna's COVID-19 vaccine candidate appears to be safe and provide some immunity, new data from early trial showsIt's too early to say whether the vaccine candidate can protect someone from the coronavirus that causes COVID-19, but early trials are encouraging.
Read more »